Richard E. Lowenthal's most recent trade in ARS Pharmaceuticals Inc was a trade of 767,600 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 767,600 | 767,600 | - | - | Stock option (right to buy) | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 261,900 | 261,900 | - | - | Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | E. Lowenthal Richard | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.67 per share. | 17 Dec 2024 | 50,000 | 1,297,447 | - | 11.7 | 583,575 | Common Stock |
| ARS Pharmaceuticals Inc | Lowenthal Richard E. | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.67 per share. | 17 Dec 2024 | 50,000 | 1,098,499 | - | 11.7 | 583,525 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.16 per share. | 10 Dec 2024 | 50,000 | 1,148,499 | - | 13.2 | 658,155 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 10 Dec 2024 | 50,000 | 1,246,494 | - | 13.2 | 658,265 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 13,789 | 20,684 | - | - | Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 06 Dec 2024 | 13,789 | 3,421,636 | - | 1.4 | 19,856 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.42 per share. | 06 Dec 2024 | 11,876 | 4,327,189 | - | 8.4 | 99,996 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 11,876 | 338,124 | - | - | Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 11,876 | 1,088,124 | - | - | Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.42 per share. | 06 Dec 2024 | 11,876 | 3,433,512 | - | 8.4 | 99,996 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.95 per share. | 19 Nov 2024 | 50,000 | 1,347,447 | - | 14.0 | 697,510 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.95 per share. | 19 Nov 2024 | 50,000 | 1,198,499 | - | 13.9 | 697,450 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.76 per share. | 12 Nov 2024 | 45,124 | 1,253,375 | - | 16.8 | 756,296 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.76 per share. | 12 Nov 2024 | 45,045 | 1,301,449 | - | 16.8 | 754,905 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.64 per share. | 12 Nov 2024 | 4,955 | 1,296,494 | - | 17.6 | 87,421 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.64 per share. | 12 Nov 2024 | 4,876 | 1,248,499 | - | 17.6 | 86,020 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.88 per share. | 15 Oct 2024 | 50,000 | 1,298,499 | - | 14.9 | 743,820 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.86 per share. | 15 Oct 2024 | 48,550 | 1,398,897 | - | 14.9 | 721,657 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 15 Oct 2024 | 1,450 | 1,397,447 | - | 15.3 | 22,118 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.83 per share. | 08 Oct 2024 | 50,000 | 1,348,499 | - | 13.8 | 691,390 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.83 per share. | 08 Oct 2024 | 50,000 | 1,346,494 | - | 13.8 | 691,385 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.93 per share. | 17 Sep 2024 | 50,000 | 1,398,499 | - | 12.9 | 646,680 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.93 per share. | 17 Sep 2024 | 50,000 | 1,447,447 | - | 12.9 | 646,525 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 10 Sep 2024 | 50,000 | 1,448,499 | - | 11.5 | 574,910 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 10 Sep 2024 | 50,000 | 1,396,494 | - | 11.5 | 574,865 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.76 per share. | 20 Aug 2024 | 36,216 | 1,512,283 | - | 14.8 | 534,461 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.76 per share. | 20 Aug 2024 | 35,944 | 1,511,503 | - | 14.8 | 530,408 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 20 Aug 2024 | 11,756 | 1,499,747 | - | 15.6 | 183,545 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.62 per share. | 20 Aug 2024 | 11,523 | 1,500,760 | - | 15.6 | 180,028 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.26 per share. | 20 Aug 2024 | 2,300 | 1,497,447 | - | 16.3 | 37,395 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.25 per share. | 20 Aug 2024 | 2,261 | 1,498,499 | - | 16.3 | 36,748 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.76 per share. | 13 Aug 2024 | 35,401 | 1,446,494 | - | 12.8 | 451,880 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.77 per share. | 13 Aug 2024 | 35,363 | 1,548,499 | - | 12.8 | 451,441 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.77 per share. | 13 Aug 2024 | 14,637 | 1,583,862 | - | 11.8 | 172,327 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 13 Aug 2024 | 14,599 | 1,481,895 | - | 11.8 | 171,908 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.40 per share. | 16 Jul 2024 | 50,000 | 1,547,447 | - | 11.4 | 570,140 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.40 per share. | 16 Jul 2024 | 50,000 | 1,598,499 | - | 11.4 | 570,155 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.62 per share. | 09 Jul 2024 | 50,000 | 1,648,499 | - | 9.6 | 480,840 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.62 per share. | 09 Jul 2024 | 50,000 | 1,496,494 | - | 9.6 | 480,885 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.14 per share. | 11 Jun 2024 | 48,028 | 1,698,499 | - | 9.1 | 439,202 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.15 per share. | 11 Jun 2024 | 47,834 | 1,546,494 | - | 9.1 | 437,461 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 11 Jun 2024 | 2,166 | 1,594,328 | - | 9.0 | 19,498 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 11 Jun 2024 | 1,972 | 1,746,527 | - | 9.0 | 17,756 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.06 per share. | 14 May 2024 | 44,746 | 1,597,447 | - | 9.1 | 405,314 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.06 per share. | 14 May 2024 | 44,350 | 1,748,499 | - | 9.1 | 401,709 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 14 May 2024 | 2,884 | 1,795,615 | - | 9.0 | 25,973 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 14 May 2024 | 2,873 | 1,644,574 | - | 9.0 | 25,881 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.04 per share. | 14 May 2024 | 2,766 | 1,792,849 | - | 9.0 | 25,005 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.05 per share. | 14 May 2024 | 2,381 | 1,642,193 | - | 9.1 | 21,559 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.34 per share. | 07 May 2024 | 50,000 | 1,798,499 | - | 9.3 | 467,230 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.34 per share. | 07 May 2024 | 50,000 | 1,596,494 | - | 9.3 | 467,135 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2024 | 82,733 | 0 | - | - | Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 23 Apr 2024 | 82,733 | 3,359,587 | - | 0.8 | 69,496 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2024 | 48,260 | 34,473 | - | - | Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 23 Apr 2024 | 48,260 | 3,407,847 | - | 1.4 | 69,494 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 19 Apr 2024 | 119,047 | 4,245,869 | - | 0.8 | 99,999 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 119,047 | 117,333 | - | - | Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 19 Apr 2024 | 69,444 | 4,315,313 | - | 1.4 | 99,999 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 69,444 | 166,936 | - | - | Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.28 per share. | 16 Apr 2024 | 50,000 | 1,848,499 | - | 9.3 | 463,985 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.28 per share. | 16 Apr 2024 | 50,000 | 1,647,447 | - | 9.3 | 464,020 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.28 per share. | 09 Apr 2024 | 50,000 | 1,898,499 | - | 9.3 | 463,850 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.28 per share. | 09 Apr 2024 | 50,000 | 1,646,494 | - | 9.3 | 463,885 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.12 per share. | 22 Mar 2024 | 47,635 | 1,697,447 | - | 9.1 | 434,612 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.12 per share. | 22 Mar 2024 | 47,632 | 1,948,499 | - | 9.1 | 434,575 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 22 Mar 2024 | 1,326 | 1,996,131 | - | 9.0 | 11,952 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.03 per share. | 22 Mar 2024 | 1,017 | 1,745,082 | - | 9.0 | 9,183 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.03 per share. | 19 Mar 2024 | 976 | 1,746,471 | - | 9.0 | 8,811 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.04 per share. | 19 Mar 2024 | 942 | 1,997,557 | - | 9.0 | 8,513 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 19 Mar 2024 | 372 | 1,746,099 | - | 9 | 3,348 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 19 Mar 2024 | 100 | 1,997,457 | - | 9 | 900 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.14 per share. | 13 Mar 2024 | 48,461 | 1,998,499 | - | 9.1 | 442,997 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.14 per share. | 13 Mar 2024 | 48,295 | 1,696,494 | - | 9.1 | 441,489 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 13 Mar 2024 | 1,500 | 1,744,994 | - | 9 | 13,500 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 13 Mar 2024 | 1,300 | 2,047,199 | - | 9 | 11,700 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 13 Mar 2024 | 239 | 2,046,960 | - | 9 | 2,151 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 13 Mar 2024 | 205 | 1,744,789 | - | 9 | 1,845 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 29 Feb 2024 | 1,982 | 2,048,499 | - | 9.0 | 17,867 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 29 Feb 2024 | 1,000 | 1,747,447 | - | 9.0 | 9,019 | Common Stock |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 29 Feb 2024 | 800 | 1,746,494 | - | 9.0 | 7,215 | Common Stock |
| ARS Pharmaceuticals Inc | E. Richard Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 26 Feb 2024 | 49,019 | 2,050,481 | - | 9.0 | 442,210 | Common Stock |
| ARS Pharmaceuticals Inc | E. Lowenthal Richard | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 26 Feb 2024 | 25,456 | 1,747,294 | - | 9.0 | 229,626 | Common Stock |
| ARS Pharmaceuticals Inc | E. Richard Lowenthal | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 26 Feb 2024 | 24,303 | 1,748,447 | - | 9.0 | 219,225 | Common Stock |
| ARS Pharmaceuticals Inc | E. Lowenthal Richard | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 26 Feb 2024 | 500 | 2,099,500 | - | 9.0 | 4,505 | Common Stock |
| ARS Pharmaceuticals Inc | E. Lowenthal Richard | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 26 Feb 2024 | 100 | 1,772,750 | - | 9.0 | 901 | Common Stock |
| ARS Pharmaceuticals Inc | E. Lowenthal Richard | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 26 Feb 2024 | 100 | 1,772,750 | - | 9.0 | 901 | Common Stock |
| ARS Pharmaceuticals Inc | E. Lowenthal Richard | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 May 2023 | 1,050,000 | 2,100,000 | - | 0 | Common Stock | |
| ARS Pharmaceuticals Inc | E. Richard Lowenthal | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 May 2023 | 1,050,000 | 4,126,822 | - | 0 | Common Stock | |
| ARS Pharmaceuticals Inc | Lowenthal E. Richard | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 May 2023 | 1,050,000 | 1,050,000 | - | 0 | Common Stock | |
| ARS Pharmaceuticals Inc | E. Richard Lowenthal | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 May 2023 | 1,050,000 | 3,276,854 | - | 0 | Common Stock | |
| ARS Pharmaceuticals Inc | Richard Lowenthal E. | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 880,000 | 880,000 | - | - | Stock option (right to buy) | |
| ARS Pharmaceuticals Inc | Lowenthal Richard E. | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 300,000 | 300,000 | - | - | Stock option (right to buy) | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,100,000 | 1,100,000 | - | - | Stock option (right to buy) | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 350,000 | 350,000 | - | - | Stock option (right to buy) | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 5,176,822 | 5,176,822 | - | - | Common Stock | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 4,326,854 | 4,326,854 | - | - | Common Stock | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 1,772,850 | 1,772,850 | - | - | Common Stock | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 1,772,850 | 1,772,850 | - | - | Common Stock | |
| ARS Pharmaceuticals Inc | Richard E. Lowenthal | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 236,380 | 236,380 | - | - | Employee Stock Option (right to buy) |